Cardiac resynchronization therapy: The issue of non-response

Luigi Padeletti, Alessandro Paoletti Perini, Edoardo Gronda

Research output: Contribution to journalArticlepeer-review


Cardiac resynchronization therapy reduces mortality and morbidity in heart failure patients with wide QRS and severe impairment of left ventricular systolic function, who are symptomatic despite optimal medical therapy. However, a high percentage of patients fail to show clinical or echocardiographic response to this treatment. Beyond current selection criteria, other elements, such as QRS duration and morphology, concomitant medical therapy, degree of right ventricle dysfunction, myocardial viability, presence of left ventricular dyssynchrony, and associated renal dysfunction, play a crucial role in modulating the response to cardiac resynchronization. Consequently, they should be part of the standard pre-implant evaluation, as they could be used to identify patients who are very unlikely to be responders.

Original languageEnglish
Pages (from-to)97-105
Number of pages9
JournalHeart Failure Reviews
Issue number1
Publication statusPublished - Jan 2012


  • Cardiac resynchronization therapy
  • Myocardial dyssynchrony
  • Myocardial viability
  • Non-responders
  • QRS morphology
  • Renal dysfunction
  • Right ventricular dysfunction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Cardiac resynchronization therapy: The issue of non-response'. Together they form a unique fingerprint.

Cite this